Current Report Filing (8-k)
December 26 2012 - 4:53PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): December 26, 2012
PSS WORLD MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
|
|
Florida
|
|
0-23832
|
|
59-2280364
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
4345 Southpoint Blvd.,
|
|
|
|
|
|
Jacksonville, Florida
|
|
|
|
32216
|
|
(Address of principal executive offices)
|
|
|
|
(Zip Code)
|
|
|
|
|
|
Registrant’s telephone number,
including area code
|
|
|
|
(904) 332-3000
|
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
x
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
On December 26, 2012, PSS World Medical, Inc. (the “Company”) and McKesson Corporation (“McKesson”) issued a joint press release announcing that McKesson has received notification
of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with McKesson’s proposed acquisition of the Company. A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
99.1
|
|
Joint press release dated December 26, 2012.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
PSS World Medical, Inc.
(Registrant)
|
|
|
|
|
|
December 26, 2012
|
|
|
|
/s/ David M. Bronson
|
|
|
|
By:
|
|
David M. Bronson
|
|
|
|
Its:
|
|
Executive Vice President and Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
99.1
|
|
Joint press release dated December 26, 2012.
|
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Oct 2024 to Nov 2024
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Nov 2023 to Nov 2024
